[1] DASHT BOZORG B, BHATTACCHARJEE S A,SOMAYAJI M R, et al．Topical and transdermal delivery with diseased human skin: passive and iontophoretic delivery of hydrocortisone into psoriatic and eczematous skin [J]．Drug Deliv Transl Res, 2022, 12(1): 197-212．
[2] HAY R J, JOHNS N E, WILLIAMS H C, et al．The global burden of skin disease in 2010: an analysis of the prevalence
and impact of skin conditions [J]．J Invest Dermatol, 2014,134(6): 1527-1534．
[3] 申国庆．掌握多种差异性 合理使用皮肤外用药[J]．药学与临床研究, 2015, 23(6): 626-628．
[4] 何雪瑜, 许 珂, 陈慕刁, 等．慢性皮肤病患者皮肤外用药使用知识和行为现状调查[J]．广州医科大学学报, 2019,47(3): 176-178．
[5] DALGARD F J, GIELER U, TOMAS-ARAGONES L, et al．The psychological burden of skin diseases: a crosssectional multicenter study among dermatological outpatients in 13 European countries [J]．J Invest Dermatol,2015, 135(4): 984-991．
[6] SABRI A H, OGILVIE J, ABDULHAMID K, et al．Expanding the applications of microneedles in dermatology[J]．Eur J Pharm Biopharm, 2019, 140: 121-140．
[7] CARY J H, LI B S, MAIBACH H I．Dermatotoxicology of microneedles(MNs) in man [J]．Biomed Microdevices,2019, 21(3): 66-74．
[8] PURI A , NGUYEN H X , TI J A N I A O , e t a l．Characterization of microneedles and microchannels for enhanced transdermal drug delivery [J]．Ther Deliv, 2021,12(1): 77-103．
[9] YANG D, CHEN M L, SUN Y, et al．Microneedle-mediated transdermal drug delivery for treating diverse skin diseases[J]．Acta Biomater, 2021, 121: 119-133．
[10] YANG J, LIU X L, FU Y Z, et al．Recent advances of microneedles for biomedical applications: drug delivery and beyond [J]．Acta Pharm Sin B, 2019, 9(3): 469-483．
[11] VORA L K, MOFFATT K, TEKKO I A, et al．Microneedle array systems for long-acting drug delivery [J]．Eur J Pharm Biopharm, 2021, 159: 44-76．
[12] DONNELLY R F, SINGH T R R, ALKILANI A Z, et al．Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety [J]．Int J Pharm, 2013, 451(1/2): 76-91．
[13] KAISER P, W?CHTER J, WINDBERGS M．Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems [J]．Drug Deliv Transl Res, 2021,11(4): 1545-1567．
[14] YI X, WANG C Y, YU X, et al．Chitosan/zinc nitrate microneedles for bacterial biofilm eradication [J]．J Biomed Mater Res B Appl Biomater, 2020, 109(6): 911-920．
[15] WANG Y S, YANG W H, GAO W, et al．Combination and efficiency: preparation of dissolving microneedles array loaded with two active ingredients and its anti-pigmentation effects on guinea pigs [J]．Eur J Pharm Sci, 2021, 160:105749．
[16] 张楚晗, 刘笑芬, 张 菁, 等．多黏菌素B诱发皮肤色素沉着的机制研究[J]．中国感染与化疗杂志, 2020, 20(3):331-334．
[17] 杨 益, 刘 陶, 朱 姗, 等．中药治疗皮肤色素沉着类疾病研究进展 [J]．辽宁中医药大学学报, 2020, 22(10):115-119．
[18] COUTEAU C, COIFFARD L．Overview of skin whitening agents: drugs and cosmetic products [J]．Cosmetics, 2016,3(3): 27-43．
[19] LEE C A, BAEK J S, KWAG D G, et al．Enhancement of skin permeation of vitamin C using vibrating microneedles[J]．Transl Clin Pharmacol, 2017, 25(1): 15-20．
[20] AUNG N N, NGAWHIRUNPAT T, ROJANARATA T, et al．HPMC/PVP dissolving microneedles: a promising delivery platform to promote trans-epidermal delivery of alpha-arbutin for skin lightening [J]．AAPS PharmSciTech,2019, 21(1): 25．
[21] SALCIDO R S．The cicatrix: the functional stage of wound healing [J]．Adv Skin Wound Care, 2018, 31(1): 581．
[22] CARMASSI M, ERAUD J, GONELLI D, et al．Keloid scars: a case series study [J]．Ann Pathol, 2015, 35(2):148-153．
[23] BAYAT A, MCGROUTHER D A, FERGUSON M W J．Skin scarring [J]．BMJ, 2003, 326(7380): 88-92．
[24] LEE S S, YOSIPOVITCH G, CHAN Y H, et al．Pruritus,pain, and small nerve fiber function in keloids: a controlled study [J]．J Am Acad Dermatol, 2004, 51(6): 1002-1006．
[25] MARI W, ALSABRI S G, TABAL N, et al．Novel insights on understanding of keloid scar: article review [J]．J Am Coll Clin Wound Spec, 2016, 7(1-3): 1-7．
[26] PARK J, KIM Y C．Topical delivery of 5-fluorouracil-loaded carboxymethyl chitosan nanoparticles using microneedles for
keloid treatment [J]．Drug Deliv Transl Res, 2021, 11(1):205-213．
[27] TAN C W X, TAN W D, SRIVASTAVA R, et al．Dissolving triamcinolone-embedded microneedles for the treatment of keloids: a single-blinded intra-individual controlled clinical trial [J]．Dermatol Ther(Heidelb), 2019, 9(3): 601-611．
[28] EL-DOMYATI M, BARAKAT M, AWAD S, et al．Microneedling therapy for atrophic acne scars: an objective evaluation [J]．J Clin Aesthet Dermatol, 2015, 8(7): 36-42．
[29] SITOHANG I B S, SIRAIT S A P, SURYANEGARA J．Microneedling in the treatment of atrophic scars: a systematic review of randomised controlled trials [J]．Int Wound J,2021, 18(5): 577-585．
[30] TAKESHITA J, GREWAL S, LANGAN S M, et al．Psoriasis and comorbid diseases: epidemiology [J]．J Am Acad Dermatol, 2017, 76(3): 377-390．
[31] GRIFFITHS C E, BARKER J N．Pathogenesis and clinical features of psoriasis [J]．Lancet, 2007, 370(9583): 263-271．
[32] HU S C, CHEN G S, TU H P．Epidemiology of depression in patients with psoriasis: a nationwide population-based
cross-sectional study [J]．Acta Derm Venereol, 2019,99(6): 530-538．
[33] DU H Y, LIU P, ZHU J J, et al．Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis [J]．ACS Appl Mater Interfaces, 2019, 11(46): 43588-43598．
[34] YU K Y, YU X M, CAO S S, et al．Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis [J]．Acta Pharm Sin B, 2021, 11(2): 505-519．
[35] KAISER P, W?CHTER J, WINDBERGS M．Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems [J]．Drug Deliv Transl Res, 2021, 11(4): 1545-1567．
[36] PANDA A, SHETTAR A, SHARMA P K, e t a l．Development of lysozyme loaded microneedles for dermal applications [J]．Int J Pharm, 2021, 593: 120104．
[37] PERMANA A D, ANJANI Q K, SARTINI, et al．Selective delivery of silver nanoparticles for improved treatment of biofilm skin infection using bacteria-responsive microparticles loaded into dissolving microneedles [J]．Mater Sci Eng C Mater Biol Appl, 2021, 120: 111786．
[38] ARSHAD M S, ZAHRA A T, ZAFAR S, et al．Antibiofilm effects of macrolide loaded microneedle patches: prospects in
healing infected wounds [J]．Pharm Res, 2021, 38(1): 165-177．
[39] GUPTA M, GOYAL A K, PALIWAL S R, e t a l．Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis [J]．J Liposome Res, 2010, 20(4): 341-350．
[40] GUéGAN S, LANTERNIER F, ROUZAUD C, et al．Fungal skin and soft tissue infections [J]．Curr Opin Infect Dis, 2016, 29(2): 124-130．
[41] WANG F Y, ZHANG X X, CHEN G P, et al．Living bacterial microneedles for fungal infection treatment [J]．Research(Wash D C), 2020, 2020: 2760594．
[42] JAMALEDIN R, YIU C K Y, ZARE E N, et al．Advances in antimicrobial microneedle patches for combating infections[J]．Adv Mater, 2020, 32(33): e2002129．
[43] PERMANA A D, PAREDES A J, VOLPE-ZANUTTO F,et al．Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis [J]．Eur J Pharm Biopharm, 2020,154: 50-61．